Fever in the returning child traveller: Highlights for health care providers
Posted: Jun 28 2018
The Canadian Paediatric Society gives permission to print single copies of this document from our website. For permission to reprint or reproduce multiple copies, please see our copyright policy.
Recreation, globalization, migration and families visiting friends and relatives (VFRs) overseas have increased the frequency of international travel and potential exposures to tropical diseases. Young infected patients can present a diagnostic challenge to clinicians when they return to Canada, with significant consequences if untreated. High quality guidelines for screening and diagnosis exist, but care providers need to know where to access them. This practice point highlights key points in the management of fever in the returning child traveller and provides links to detailed resources on this topic.
Keywords: Children; Fever; Travel health; Tropical disease
Recreation, globalization, migration and the frequency of travel by Canadian families visiting friends and relatives (VFRs) overseas have increased international travel rates and risk for exposures to diseases not commonly seen in Canada and can present specific diagnostic challenges to clinicians upon their return. Although children travel abroad less frequently than adults, they bear a disproportionately high burden of travel-related infections . As a group, VFRs are at higher risk for infection than other types of travellers because they:
- are less likely to seek pre-departure advice and more likely to travel for longer periods,
- are more likely to be exposed to local food, drink and infectious contacts, for longer periods
- often underappreciate the severity of certain endemic infections
- often underappreciate that immunity to malaria wanes over time 
The mortality of some travel-related illnesses, such as malaria, can be high when cases are unrecognized or improperly managed. Clinicians in Canada need to be able to identify serious, treatable infections in a timely manner, to consider risk for diseases that pose a public health risk, and to make appropriate arrangements for treatment and referral. Although this practice point focuses on travel-related illness, clinicians should be aware that many infections in returning child travellers are also common in Canada (i.e., influenza, viral gastroenteritis, otitis media).
The Canadian Paediatric Surveillance Program (CPSP) report for 2008-2009 and later data from CanTravNET surveillance for 2009-2011 showed that potentially life-threatening infections, such as dengue malaria and enteric fever, are commonly imported into Canada by returning travellers, especially VFRs .
Key resources  to help guide clinical assessment, management and referral of fever in the returning child traveller
KEY COMPONENTS OF THE TRAVEL HISTORY
With every family seen in clinical practice, be sure to ask about travel outside of Canada in the previous 12 months. Each component of a travel history provides key information regarding potential disease exposure and can narrow differential diagnosis significantly. For example, given that incubation periods vary and infections may be seasonal, obtaining precise travel dates is essential for risk assessment and diagnosis.
Ask for specifics about:
- Travel details and disruptions: Including destinations, dates and timing of symptom onset
- Setting: Rural versus urban, living conditions, altitude, season (i.e., rainy or dry)
- Activities: VFR or professional, community involvement, environments
- Potential exposures: Food consumption and handling/preparation (with risk for exposure to unpasteurized dairy, meat, seafood); drinking water and fresh water sources (i.e., for swimming, washing); sick contacts; insect bites (especially mosquitos, ticks); animal bites or other animal exposures; sexual encounters (when appropriate)
- Pre-travel preparation: Counselling, vaccinations, malaria chemoprophylaxis, personal protective equipment (clothing, insect nets and repellant): http://www.cps.ca/documents/position/preventing-mosquito-and-tick-bites
- Medical care: Health care contacts and medications received while travelling and since return.
HOST RISK FACTORS
Careful attention should be paid to factors that put a child at greater risk for severe infection, including:
- Being unvaccinated or incompletely vaccinated
- Having a history of compromised or suppressed immunity (e.g., splenic dysfunction)
- Low weight or poor nutritional status
- Very young age (i.e., less than one month)
It is important to perform a complete physical examination, including vitals signs, but the absence of localized findings does not rule out a serious infection. Findings on exam that can be diagnostic clues when interpreted in context with travel history and incubation period are outlined in Table 1 .
Hepatitis A, B, E
Viral hemorrhagic fever (VHF)
Lymph node enlargement
Epstein-Barr virus (EBV)
Mycobacterium tuberculosis (mTB)
Hepatitis A, B, E
Rocky Mountain spotted fever (RMSF)
Fever and rash
Viral exanthems (i.e., Roseola)
Enteric fever (Salmonella)
Fever and low WBC count
Enteric fever (Salmonella)
Fever and eosinophilia
Other parasites, particularly if child is immunocompromised
Fever onset >2 weeks
Enteric fever (Salmonella)
Amoebic liver abscess
Fever onset <2 weeks
Viral upper or lower respiratory tract infections
Acute otitis media
Urinary tract infection
Three of the most important travel-related causes of fever are malaria (20% to 30% of cases, onset within 6 months of return), traveller’s diarrhea and enteric fever (10% to 20% and 2% to 7% respectively, onset within 60 days of return), and dengue (5%, within 14 days of return) . Respiratory tract infections occur worldwide and are common, but it is important to exclude infections that are life-threatening or highly contagious.
Malaria is an important cause of systemic febrile illness in the returning traveller. Malaria is transmitted by Anopheles mosquitoes, which bite in the evening and at night. Malaria is a medical emergency, with a mortality rates as high as 20% in Plasmodium falciparum malaria. If a febrile child has travelled in the last 6 months to an area where malaria is endemic, a malaria diagnosis must be excluded specifically. Symptoms in children are non-specific and may include fever and/or chills, headache, nausea with or without vomiting or diarrhea, lethargy, myalgia and abdominal pain. The risk for acquiring malaria is highest in Africa, but physicians should consult the CDC or PHAC websites (see the links above) for a complete list of countries where malaria is endemic. Diagnosis is made by microscopy +/- rapid diagnostic testing, when available. Initially, all children and youth with suspected P falciparum malaria should be admitted to hospital and treated presumptively for chloroquine-resistant malaria until speciation becomes available. Urgent consultation with an infectious disease expert should be sought. Access to artesunate or quinine for malaria treatment is through the Canadian Malaria Network . Detailed information on the diagnostic criteria for severe malaria and treatment can be found through CATMAT  and the Canadian Paediatric Society .
Enteric (typhoid) fever is caused by infection with Salmonella typhi or Salmonella paratyphi from water or food contaminated with feces. Travellers to endemic areas, such as the Indian subcontinent, Southeast Asia, South and Central America, Africa and Eastern Europe, are at high risk.
The incubation period is usually 7 to 14 days. Symptoms of typhoid fever may be biphasic, presenting initially as enterocolitis with diarrhea lasting several days, resolving, then recurring with more non-specific symptoms, including fever, chills, rash, diaphoresis, headache, myalgias, confusion, psychosis or apathy. Constipation occurs in 10% to 20% of cases, and about 20% of cases experience abdominal pain. Infected children may look unwell and show hepatosplenomegaly on exam. Leukopenia and thrombocytopenia may also be present. Blood culture is important for diagnosis, and more than one sample may be required to increase diagnostic yield .
Diarrhea is a common post-travel complaint and is typically caused by an enteric infection that can be viral, bacterial or parasitic. Symptoms can be acute (if onset is <2 weeks, rotavirus or bacterial infection is usually the cause), or chronic (>2 weeks i.e., post-infectious diarrhea, giardiasis). The main treatment consideration is hydration. There may be a role for antimicrobials when a child’s stools are bloody (dysenteric). For more on this topic, see the CATMAT statement on traveller’s diarrhea .
Dengue is caused by a flavivirus, which is transmitted by mosquitoes that bite during the day and breed in stagnant water, usually in urban areas. Regions at high risk for dengue include Southeast Asia (especially Thailand), the South Pacific, Central America and the Caribbean.
The incubation period for dengue varies from 2 to 14 days. Symptoms may include high fever, chills, headache, myalgias and a classic erythematous reticulate rash over the thorax, face and flexion areas. Lymphocytosis, neutropenia and elevated aminotransferases are also characteristic signs of dengue infection. However, all these symptoms can be caused by other arboviruses. Repeat dengue infections can present as hemorrhagic dengue or as shock syndrome, with hyponatremia, hypoproteinemia and circulatory collapse.
Management of dengue is supportive, including rest, fluids, antipyretics, analgesia and transfusion, when indicated. Bacterial sepsis and malaria should always be ruled out. Use of steroids, non-steroidal anti-inflammatory drugs (NSAIDs) and acetylsalicylic acid (ASA, aspirin) should be avoided due to bleeding risk .
In non-immune or unvaccinated children, infectious hepatitis is a consideration.
In recent years, emerging pathogens such as Chikungunya virus and Zika virus, and highly transmissible infections, such as viral hemorrhagic fever (e.g., Ebola), coronaviruses (e.g., Middle East Respiratory Syndrome-CoV), have garnered widespread attention. Consult the CDC or PHAC websites for up-to-date information on emerging travel-related infections or local outbreaks (e.g., measles, Dengue).
GENERAL APPROACH TO CARE FOR THE RETURNING CHILD TRAVELLER WITH FEVER
1. Take an initial travel history.
2. Institute isolation precautions based on presenting symptoms .
3. Obtain a detailed history of exposures and perform a full physical exam, including skin examination.
- Complete blood count with differential: liver enzymes; electrolytes; creatinine
- Malaria smears ± antigen detection testing, when available (immediately and at least 2 subsequent samples over 24 to 48 hours when the child has visited a malaria-endemic area)
- Blood culture (ensure adequate weight or age-based volume collected)
- Urinalysis +/– urine culture
- Stool culture for enteropathogens x 1 (Salmonella, Shigella, Campylobacter, Yersinia, E coli O157:H7)
- Chest x-ray
- Stool for ova and parasites, particularly if diarrhea is chronic or patient is immunocompromised (Cyclospora, Cryptosporidium, Entamoe bahistolytica, Giardia)
- Viral serology: Acute serology should be saved in the laboratory and paired with convalescent serology if a diagnosis has not been reached within 10 to 14 days. Examples: Dengue serology when fever onset occurs within 14 days of return from South or Southeast Asia, Latin America or some areas of the Caribbean; Chikungunya serology when a child has returned from travel to Southeast Asia, Latin America or the Carribean; Zika virus or arboviruses .
***Ensure that travel history is included on all lab and radiologic requisitions.
When travel history includes a malaria-endemic area and the child is unwell or lab diagnosis may be delayed, empiric treatment for P falciparum malaria should be initiated presumptively (http://publications.gc.ca/collections/collection_2014/aspc-phac/HP40-102-2014-eng.pdf), including broad-spectrum antibiotics with gram-negative coverage. Remember that a well-appearing child with P falciparum malaria can deteriorate quickly, and malaria can also present as a co-infection with pneumonia or bacteremia . In critically ill cases or when a child’s condition is worsening, prompt consultation with an infectious diseases specialist is warranted. Also, supportive therapy, such as fluids for severe diarrheal illness, should be initiated promptly.
When malaria and bacteremia have been excluded in the well-appearing, clinically stable child, initiate targeted therapy based on the individual’s history, physical exam and results of investigations and make arrangements for adequate follow-up.
This practice point was reviewed by the Infectious Diseases and Immunization Committee, the Community Paediatrics Committee and executive members of the Paediatric Emergency Section of the Canadian Paediatric Society.
CANADIAN PAEDIATRIC SOCIETY GLOBAL CHILD AND YOUTH HEALTH SECTION
Executive members: Dominic Allain MD (President), Robert Bortolussi MD (Past President), Mahli Brindamour MD (President-Elect), Andrea Evans MD (Member-at-Large), Jennifer Turnbull MD (Secretary-Treasurer), Ashley Vandermorris MD (Member-at-Large)
Liaisons: Funmbi Babalola MD (CPS Residents Section)
Principal authors: Tobey Audcent MD, Andrea Hunter MD
- Hagmann S, Neugebauer R, Schwartz E, et al. Illness in children after international travel: Analysis from the GeoSentinel Surveillance Network. Pediatrics 2010;125(5):e1072-80.
- Crockett M. Canadian children who travel abroad: What are the risks? Paediatr Child Health 2009;14(3):160-76.
- Boggild AK, Geduld J, Libman M, et al. Travel-acquired infections and illnesses in Canadians: Surveillance report from CanTravNet surveillance data, 2009-2011. Open Med 2014;8(1):e20-32.
- Canadian Paediatric Surveillance Program. Travel-related illnesses in paediatric travellers who visit friends and relatives abroad: Final report. CPSP 2011 Results. Ottawa: Canadian Paediatric Society.
- Hui CP; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. The Committee to Advise on Tropical Medicine and Travel (CATMAT): A reference for Canadian paediatricians. Paediatr Child Health 2015;20(8):437-40.
- Halbert J, Shingadia D, Zuckerman JN. Fever in the returning child traveller: Approach to diagnosis and management. Arch Dis Child 2014;99(10):938-43.
- Centers for Disease Control and Prevention. CDC Yellow Book 2018: Health Information for International Travel. New York, N.Y.: Oxford University Press, 2018.
- Public Health Agency of Canada, Committee to Advise on Tropical Medicine and Travel (CATMAT). Fever in the returning international traveller: Initial assessment guidelines. Can Commun Dis Rep 2011;37(ACS-3): https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/11vol37/acs-3/pdf/returningtravellerfever-fievrevoyageurderetour-eng.pdf (Accessed April 10, 2018).
- West NS, Riordan FA. Fever in returned travellers: A prospective review of hospital admissions for a 2(1/2) year period. Arch Dis Child 2003;88(5):432-4.
- Public Health Agency of Canada. Medical Access to Artesunate or Quinine for Malaria Treatment Streamlined in Canada through the Canadian Malaria Network (CMN): https://www.canada.ca/en/public-health/services/travel-health/medical-access-artesunate-quinine-malaria-treatment.html (Accessed April 10, 2018).
- Public Health Agency of Canada. Committee to Advise on Tropical Medicine and Travel (CATMAT). Canadian Recommendations for the Prevention and Treatment of Malaria: An Advisory Committee Statement, 2014: http://publications.gc.ca/collections/collection_2014/aspc-phac/HP40-102-2014-eng.pdf (Accessed April 10, 2018).
- Onyett H; Canadian Paediatric Society. Malaria. Caring for Kids New to Canada, updated March 2018: http://www.kidsnewtocanada.ca/conditions/malaria
- Public Health Agency of Canada. Committee to Advise on Tropical Medicine and Travel (CATMAT). Summary of the Statement on International Travellers and Typhoid by CATMAT, February 20, 2014. Can Com Dis Rep 2014;40-4: https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2014-40/ccdr-volume-40-4-february-20-2014/ccdr-volume-40-4-february-20-2014-1.html (Accessed April 10, 2018).
- Public Health Agency of Canada. Committee to Advise on Tropical Medicine and Travel (CATMAT). Statement on Travellers’ Diarrhea, 2015: https://www.canada.ca/en/public-health/services/travel-health/about-catmat/statement-travellers-diarrhea.html (Accessed April 10, 2018).
- Public Health Agency of Canada. Committee to Advise on Tropical Medicine and Travel (CATMAT). Statement on Dengue: An Advisory Committee Statement (ACS). Can Com Dis Rep 2009;35(ACS-2): http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/09pdf/acs-dcc-2.pdf (Accessed April 10, 2018).
- Centers for Disease Control. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings (updated October 2017): https://www.cdc.gov/infectioncontrol/pdf/guidelines/isolation-guidelines.pdf (Accessed April 10, 2018)
- Thwaites GE, Day NPJ. Approach to Fever in the Returning Traveler. New Engl J Med 2017;376:548-60.
Disclaimer: The recommendations in this position statement do not indicate an exclusive course of treatment or procedure to be followed. Variations, taking into account individual circumstances, may be appropriate. Internet addresses are current at time of publication.